Analyst consensus rating

Kazia Therapeutics Analyst Rating: Strong Buy

Direct answer

Kazia Therapeutics's consensus rating is Strong Buy.

9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $28.30.
Forecast evidence checked November 16, 2026.

Get free Kazia Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$6.62
Average price target
$28.30
High price target
$38.47
Low price target
$16.95
Low target gap
+156%
Target upside
+327.4%
High target gap
+481.1%
Target range width
325.1%
Consensus rating
Strong Buy
Analysts
9
Evidence date
November 16, 2026
Valid through
November 23, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Kazia Therapeutics?

Kazia Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $28.30.

How far are Kazia Therapeutics's low and high targets from the recorded price?

The low target implies +156%, while the high target implies +481.1%.

How many analysts are included in Kazia Therapeutics's consensus?

The verified consensus includes 9 analysts.

How is Kazia Therapeutics's target upside or downside calculated?

The average target of $28.30 is divided by the recorded price of $6.62, then one is subtracted to produce +327.4%. This does not guarantee a future return.

When was Kazia Therapeutics's analyst forecast verified?

The data was verified on 2026-11-16. The dataset is valid through 2026-11-23.